Nottingham Galway - National University of Ireland, Galway

More documents

Recommendations

Info

Professor Phil Drew Phil Drew Dr John Kennedy John Kennedy 20 Professor Philip J Drew is a Professor / Honorary Consultant Breast Surgeon within the Hull York Medical School. He qualified from St Mary’s Hospital, London in 1990. He was awarded an MD with honours from the University of Hull for his thesis on the clinical application of breast MRI and a MS from the University of London for his work on artificial neural networks and prognostication. His clinical training was in London, Yorkshire (as Professor Kerin’s lecturer) and the Cardiff Breast Unit. His team’s breast research interests include the immunology and genetics of breast cancer including proteomic investigation of mechanisms of radio/chemoresistance, prediction of outcome with artificial intelligence techniques and applications of MRI. With support from his NHS colleagues his clinical activity includes an extensive oncoplastic breast practice which has provided opportunities for qualitative research and the development of novel surgical techniques. He has previously been awarded a Hunterian Professorship from the Royal College of Surgeons of England. He has produced more than 100 academic papers and contributed to several books on breast surgery. He acts as surgical advisor to the randomised multicentre UK HTA trial of comparing MRI and mammographic planning for breast conserving surgery (COMICE) and the recently approved NEO-COMICE trial. Dr. Kennedy holds the position as Consultant Medical Oncologist at St James’s Hospital and St. Lukes Hospital and Director of the Cancer Clinical Trials Consortium at St James's Hospital. Dr. Kennedy holds a Bachelor of Medicine, a Bachelor of Surgery and a Bachelor of Obstetrics from the University of Dublin, Trinity College where he was awarded a first class degree and won the university Gold Medal in 1983. His training took him from Ireland to the United States where he began a Clinical Fellowship in Oncology at the renowned Johns Hopkins University in Baltimore in 1987 and rose to the position of Associate Professor of Oncology before returning to Ireland in 1998. He is the Chairman of the Irish Clinical Oncology Research Group (ICORG), immediate past Chairman of the Irish Society for Medical Oncology, and Chairman of the Medical Committee of the Irish Cancer Society. His major research interest is in breast cancer.
Professor Carlos Caldas Carlos Caldas Professor John Robertson John Robertson Professor of Cancer Medicine, University of Cambridge. Senior Group Leader, Cancer Research UK Cambridge Research Institute, Honorary Consultant Medical Oncologist, Addenbrooke’s Hospital. Professor Caldas currently holds the Chair of Cancer Medicine at the University of Cambridge. He heads the Breast Cancer Functional Genomics Laboratory at the new Cancer Research UK Cambridge Research Institute. He is an Honorary Consultant Medical Oncologist at Addenbrooke’s Hospital. He is also Lead of the Cambridge Experimental Cancer Medicine Centre and Director of the Cambridge Breast Cancer Research Unit which will open at Addenbrooke’s Hospital later this year. He is a Fellow of the American College of Physicians and the Royal College of Physicians. His current research interests are in the use of genomics, transcriptomics and proteomics towards clinical applications in breast cancer to improve prognostication, individualization of treatment through pharmacogenetics/pharmacogenomics and experimental therapeutics. He has also a research program on the genetics of gastric cancer. His main clinical interest is in breast cancer chemotherapy and novel molecularly targeted therapies. He has published over 100 peer-reviewed papers including in Nature Genetics, Nature Medicine, Nature, Cell, New England Journal of Medicine, PNAS, Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, Genome Biology and Oncogene. John Robertson is Professor of Surgery at the University of Nottingham and works as a Consultant Surgeon at the City Hospital, Nottingham, UK. Professor Robertson’s major clinical and academic research interest lies in breast cancer. A longstanding and major area of research has been endocrine and growth factor therapies in breast cancer. More recently he has been involved in developing a blood test for screening and early detection. Professor Robertson is a member of the Steering Committee of the Early Breast Cancer Clinical Trialists Group (EBCCTG) which oversees the quinquenial ‘Oxford Overview’ of adjuvant therapy trials, the National Committee of the Association of Breast Surgeons at BASO, the Society for Academic and Research Surgery, the British Association of Cancer Research, the British Breast Group, the Association of Surgeons of Great Britain & Ireland, the European Society of Mastology and the European Group for Breast Cancer Screening. To date, Professor Robertson has published over 230 scientific papers in refereed journals, written a number of book chapters and edited three books. He is the editor of Breast Cancer Online (bco.org). 21
Page 1 and 2: Nottingham Galway & INTERNATIONAL B
Page 3 and 4: Contents 2 Invitation from Professo
Page 5: Introduction from Professor Roger B
Page 8 and 9: Thursday, 18th June 2009 6 8.30 Reg
Page 10 and 11: Friday, 19th June 2009 8 9.00 Regis
Page 13 and 14: Participants NUI Galway
Page 15 and 16: Professor Gordan Wishart Gordan Wis
Page 17 and 18: Ms Carmel Malone Carmel Malone Mr K
Page 19 and 20: Professor Nigel Bundred Nigel Bundr
Page 21: Professor Mike Dixon Mike Dixon Mr
Page 25 and 26: Professor Carsten Rose Carsten Rose
Page 27 and 28: Mr Martin O’Sullivan Martin O’
Page 29 and 30: Professor Tom Gorey Tom Gorey Dr Ai
Page 31 and 32: Professor Robert Mansel Robert Mans
Page 33 and 34: Mr Denis Evoy Denis Evoy Dr Valerie
Page 35 and 36: Continuing Professional Development
Page 37 and 38: ✃ The Docks Galway
Page 39 and 40: The Claddagh Galway

Nottingham Galway - National University of Ireland, Galway

Create successful ePaper yourself

Delete template?

Save as template?